IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 417.32 USD -2.63%
Market Cap: 34.2B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

IDEXX Laboratories Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDEXX Laboratories Inc
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
IDEXX Laboratories Inc
NASDAQ:IDXX
Selling, General & Administrative
-$1B
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
Becton Dickinson and Co
NYSE:BDX
Selling, General & Administrative
-$4.9B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Selling, General & Administrative
-$5.8B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Selling, General & Administrative
-$7.2B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Abbott Laboratories
NYSE:ABT
Selling, General & Administrative
-$11.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-6%
Intuitive Surgical Inc
NASDAQ:ISRG
Selling, General & Administrative
-$2.1B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
No Stocks Found

IDEXX Laboratories Inc
Glance View

Market Cap
34.3B USD
Industry
Health Care
Economic Moat
Narrow

IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster their presence in both developed and emerging markets. For investors, IDEXX represents a compelling opportunity within a steadily growing sector. The company's recurring revenue model, driven by its suite of diagnostic tests and subscriptions to software solutions, ensures stable cash flow and predictability in earnings. IDEXX has also demonstrated impressive financial performance, characterized by strong revenue growth, high profit margins, and a commitment to shareholder returns. By harnessing trends in pet ownership and increasing expenditures on pet healthcare, IDEXX positions itself as a reliable player in the marketplace. With its dedication to innovation, customer service, and global expansion, IDEXX Laboratories Inc. stands poised for sustained growth, making it an attractive consideration for long-term investors.

IDXX Intrinsic Value
255.66 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is IDEXX Laboratories Inc's Selling, General & Administrative?
Selling, General & Administrative
-1B USD

Based on the financial report for Sep 30, 2024, IDEXX Laboratories Inc's Selling, General & Administrative amounts to -1B USD.

What is IDEXX Laboratories Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-9%

Over the last year, the Selling, General & Administrative growth was -14%. The average annual Selling, General & Administrative growth rates for IDEXX Laboratories Inc have been -9% over the past three years , -9% over the past five years , and -9% over the past ten years .

Back to Top